Negative symptoms in individuals at clinical high risk of psychosis. - Wikidata - wikimedia - TriplyDB

Negative symptoms in individuals at clinical high risk of psychosis.

Negative symptoms in individuals at clinical high risk of psychosis.

http://www.wikidata.org/entity/Q33992721

about

Treating Negative Symptoms in Schizophrenia: an Update North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection.Auditory event-related potentials and α oscillations in the psychosis prodrome: neuronal generator patterns during a novelty oddball task.Symptom trajectories and psychosis onset in a clinical high-risk cohort: the relevance of subthreshold thought disorder.Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study.The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.Antipsychotics and amotivation Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function.Functional neuroimaging abnormalities in youth with psychosis spectrum symptoms.Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms.Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.INCREASED INTERNET USE AND POORER ABILITY TO MANAGE EMOTIONS IN YOUTH AT HIGH-RISK FOR PSYCHOSIS Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis.Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis.Emotional Experiences Predict the Conversion of Individuals with Attenuated Psychosis Syndrome to Psychosis: A 6-Month Follow up Study.Frontal-striatum dysfunction during reward processing: Relationships to amotivation in schizophrenia Negative symptom measurement in individuals at-risk for psychosis.Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders.Prediction and prevention of the first psychotic episode: new directions and opportunities.Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS).A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis.Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting.Prediction and prevention of psychosis: current progress and future tasks.Reinforcement Learning Performance and Risk for Psychosis in Youth.Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome.Validation of the Korean Version of the Clinical Assessment Interview for Negative Symptoms.Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.Attenuated positive psychotic symptoms and the experience of anhedonia.Achievement motivation in early schizophrenia: Relationship with symptoms, cognition and functional outcome.

P2860

Q26744805-D583FDBC-6D85-4066-BD8F-2840500989C2 Q27011767-8668AB5D-E50D-4911-BF32-1618C180C9BD Q30368928-CA745948-6D6C-40F3-96D6-7973FEC333C2 Q30371792-A6692B15-C469-4281-9AAE-10FF10899758 Q30405077-914320B7-EA3A-41F1-94D7-8A48D5ED0B51 Q30427083-8781EE6F-E6F6-4581-BB88-AFCE310066EE Q30576344-699E37BA-999E-4E9B-8F3A-897F89185DDB Q30604468-C30BCB55-950F-462A-A429-99E2DE4E65DB Q33707483-E79D2820-5BF3-4453-96AC-40D75E4B3A62 Q34322953-3D06AAC2-F155-428D-B1DC-45BA563A9E1E Q34669646-9DB5D6DD-AD1C-4505-8DAF-D87F10099E4A Q35185253-36877F10-2CC2-499B-906C-F9993468F920 Q35421296-D3E45E0F-FF97-43CE-AD93-78151BE94D44 Q35639344-05A4D786-09CC-4441-B92E-68A4DA7E5B1C Q35883039-FECFA6E3-117A-4F11-BF2A-32EA64E64426 Q36089987-0F095649-4C5E-4682-8845-91488D56929C Q36371727-D45F1658-D036-41CB-9BD4-CC75B920FFF9 Q36378238-257DE105-4377-4D48-83CC-68C6F45B4E67 Q36542913-35A9088F-ABF3-4CAE-9F71-B6A2C59F9E8A Q36809759-70C189B0-EE1D-4320-8FC9-CD0E7C26B7F4 Q36817178-B68B47ED-5821-45FD-AC17-F85B07B94472 Q36858411-11EB5AE0-2698-43A3-B4AA-05625C52FB9B Q36955474-FC43A057-B010-4BEC-9AD5-CF340C15A760 Q37463028-D4FE10E1-EC64-4F33-82F2-7F7849E8919E Q37472593-AEB5346F-D6D1-4172-83BC-D0B0434CF698 Q37625137-3BAA3032-1C34-48B5-95B9-E31C9BAB4790 Q37682795-05F0186F-A27B-49D9-929E-23CF8CFC039D Q37696740-8DE25C56-133E-4F3A-B286-392658490522 Q38756852-BD4E1C06-AABB-491F-820A-F1D406A73C12 Q38758518-E43529B6-2B2D-4E2C-B3A6-06B46C8427DD Q38819011-9B6F92A4-5479-4642-B9AE-9425F6AB79B6 Q39018992-5AA9E766-8C53-4942-91A2-847987370E26 Q39123249-A3727F68-D25C-4D94-ACAA-35B4B30FFFFC Q41046867-F9AB764B-5FC5-417F-8C9F-3F7CD6EB9321 Q41197083-9FFECBA8-37EA-4CD0-929E-1C8E45629E57 Q41449680-153BF4BC-2BFA-4666-8F00-89325DBA1C96 Q41651638-4355DC0D-1C71-48C9-A609-8B00A0D0D0B4 Q46228189-95D8AE29-94F5-4B97-BAFD-E1D089BFF897 Q46429476-E3954F85-496F-4D92-8BB8-7B70E396857C Q47362182-96DC4B53-650E-483C-BD60-7DFD501714D8

P2860

Negative symptoms in individuals at clinical high risk of psychosis.

http://www.wikidata.org/entity/Q33992721

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Negative symptoms in individuals at clinical high risk of psychosis.

@ast

Negative symptoms in individuals at clinical high risk of psychosis.

@en

type

label

Negative symptoms in individuals at clinical high risk of psychosis.

@ast

Negative symptoms in individuals at clinical high risk of psychosis.

@en

prefLabel

Negative symptoms in individuals at clinical high risk of psychosis.

@ast

Negative symptoms in individuals at clinical high risk of psychosis.

@en

P1433

Q33992721-0BB319C7-235D-446E-9DB6-0B726A4513E3

P1476

Q33992721-0EA73A1D-FBB9-4894-9A71-577D627E453D

P2093

Q33992721-0E0CE209-57F2-4BAE-8548-8B3AA18F2A5E

Q33992721-2D9B931B-B222-4C04-9EA9-BE5028DDA8E2

Q33992721-368E8CED-A33B-4B05-A563-D06789791BCB

Q33992721-3E182A38-FA08-4E3F-BDCD-28DCB703415B

Q33992721-CCD97133-28F9-428D-950B-DD7937825376

Q33992721-D3BF13FB-2C48-411E-BA2E-39ED69498A4B

Q33992721-DCA73450-C666-4130-AF86-B5E5F993C164

P2860

Q33992721-07036612-0BBA-4772-8F4F-67B17C6CA357

Q33992721-0D814E8F-2335-435E-9E67-0649AB1B1703

Q33992721-0FC52F14-7F1C-454C-BC66-299C3F9CC53B

Q33992721-2A118AD3-6FDF-4AA7-BAFD-39FBCBCFCC5A

Q33992721-42DF75D8-7D3A-4896-B923-4E17CE6A1C5F

Q33992721-44AF317C-D400-4900-AB1F-18423FFBBE0A

Q33992721-4E40C8E5-92C0-4394-A5A3-301889C5022F

Q33992721-58F59562-B1CF-4032-AD1B-5D57F0333FD8

Q33992721-5C44B384-3630-4FB7-AB14-D2A2B105319C

Q33992721-5EC2F309-2A17-4857-90B2-05FD4C152F8C

P304

Q33992721-8E8C5DBF-4EAF-40A9-9B02-91048D75BCDD

P31

Q33992721-A0E1B8E9-AA42-4599-AD50-4E7CB44A1172

P356

Q33992721-924F8EFC-A396-4530-A65D-5CF3A2F4035E

P407

Q33992721-41F973DC-C406-4597-AC19-90EAD84F9A0D

P433

Q33992721-5BFC1736-B111-4351-9C2E-E9AD9600EC0E

P478

Q33992721-1E35B516-F0B9-470C-BDDE-54ECC5DE8FC4

P50

Q33992721-3DE659CC-5CB5-4C1B-A802-27E83CDE6E0C

Q33992721-554FDC48-FF97-42E1-B10C-E55BD4452393

Q33992721-A8B921BC-4228-4167-82A3-044CD0706CCE

Q33992721-CCA77407-5CC5-4E0B-9BAC-87EE022153E3

Q33992721-F3EF2774-467D-4DC7-8FC6-5CA7F7C62E78

P577

Q33992721-37EF2C76-358F-4E2B-8318-DC688ACE4C59

P5875

Q33992721-CFC03667-48B7-4706-978C-420B55325579

P698

Q33992721-25043099-D980-4E35-BEF3-A693A6F02481

P921

Q33992721-36D1F7BD-113D-40E7-8D92-0D08256A63E0

P932

Q33992721-4018A0BF-2CAD-405D-A3F0-4F6549BE22E0

P356

J.PSYCHRES.2012.02.018

P1433

Psychiatry Research

P1476

Negative symptoms in individuals at clinical high risk of psychosis.

@en

P2093

Barbara A Cornblatt

http://www.w3.org/2001/XMLSchema#string

Danijela Piskulic

http://www.w3.org/2001/XMLSchema#string

Diana O Perkins

http://www.w3.org/2001/XMLSchema#string

Elaine F Walker

http://www.w3.org/2001/XMLSchema#string

Ming T Tsuang

http://www.w3.org/2001/XMLSchema#string

Robert Heinssen

http://www.w3.org/2001/XMLSchema#string

Scott W Woods

http://www.w3.org/2001/XMLSchema#string

P2860

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research

Negative symptoms in schizophrenia: avolition and Occam's razor

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.

Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.

Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders.

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

At clinical high risk for psychosis: outcome for nonconverters.

The structure of negative symptoms within schizophrenia: implications for assessment.

Risk factors for psychosis: impaired social and role functioning

P304

220-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PSYCHRES.2012.02.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

Thomas McGlashan

Kristin S Cadenhead

Larry J Seidman

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221974469

http://www.w3.org/2001/XMLSchema#string

P698

22445704

http://www.w3.org/2001/XMLSchema#string

P921

P932

4119605

http://www.w3.org/2001/XMLSchema#string